AVAILABLE FOR CLINICAL USE

Nuvexa 180

The gold standard in regenerative biologic matrices. High-concentration Wharton's Jelly derived exosomes for advanced tissue regeneration.

180B

EXOSOMES / VIAL

MSC

MESENCHYMAL ORIGIN

< -80ºC

CRYO PRESERVATION

REQUEST SPECIALIST QUOTE CLINICAL PROTOCOL
Nuvexa

Nuvexa 180

REGENERATIVE MATRIX

Cellular Potency Comparison

Nuvexa 180 outperforms standard exosome isolation methods. Our proprietary filtration technology preserves the structural integrity of the lipid bilayer, ensuring maximum bioavailability and signaling efficacy.

Growth Factor Concentration (pg/mL)

Nuvexa 180 2,450 pg/mL
Competitor A (BM-MSC) 1,100 pg/mL
Competitor B (Adipose) 850 pg/mL
*Data based on independent third-party analysis of VEGF, HGF, and FGF-2 levels.

hPESC Derived Formulation

Formulated from human progenitor endothelial stem cells (hPESCs), yielding a highly potent extract verified by nanoparticle tracking analysis.

Abundant Cytokine Profile

Demonstrates significant expression of clinically relevant growth factors like TGF-β1, VEGF, and the powerful anti-inflammatory cytokine IL-1RA.

Proven Identity & Purity

Membrane-enclosed particles expressing exosome tetraspanins CD81 and CD9 confirm the exceptional quality, purity, and lack of cellular debris.

ISO 7 CLEANROOM PRODUCTION

Uncompromising Manufacturing Purity

Every vial of Nuvexa 180 undergoes a rigorous 9-step purification process to remove cellular debris while maintaining exosomal integrity.

  • Sterility Testing (USP <71>)
  • Endotoxin Analysis (USP <85>)
  • Mycoplasma Detection
  • Nanoparticle Tracking Analysis (NTA)
Download Certificate of Analysis Example

99.8%

VIABILITY

0%

ADDITIVES

ISO

9001 CERTIFIED

FDA

HCT/P COMPLIANT

Ready to Incorporate Nuvexa into Your Practice?

Join the network of leading regenerative medicine specialists. Request a consultation with our medical director to discuss clinical protocols and pricing.

CONTACT SALES TEAM DOWNLOAD PRODUCT BROCHURE